Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations. // Journal of Clinical Lipidology. – URL: https://www.sciencedirect.com/science/article/pii/S1933287426004344?dgcid=rss_sd_all
Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations. Journal of Clinical Lipidology. https://www.sciencedirect.com/science/article/pii/S1933287426004344?dgcid=rss_sd_all
“Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations.” Journal of Clinical Lipidology.
@article{article100588,
title = {Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations},
journal = {Journal of Clinical Lipidology},
url = {https://www.sciencedirect.com/science/article/pii/S1933287426004344?dgcid=rss_sd_all}
}